Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

Vaccinating livestock and poultry for the H5 series of avian influenza viruses does not have support from the entire ag sector. Friday, Zoetis announced USDA issued a conditional license for it’s killed virus-derived vaccine labeled for use in chickens.

In a press release, global animal health company Zoetis announced that it received conditional approval from the USDA for a vaccine it developed for bird flu.

Bird flu has infected more than 150 million birds and close to 70 people in the U.S. since it began Egg prices are expected to rise 20% in 2025 due to the outbreak

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

Zoetis, an animal health company, confirmed that the conditional vaccine was approved on Feb. 14. “When a new strain of HPAI was identified in the US in early 2022, our scientists immediately began work to update our previous avian influenza vaccine,

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.

PARSIPPANY, N.J., February 14, 2025--(BUSINESS WIRE)--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype ...

Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes enhanced biosecurity measures and medication to control the spread of the virus and moves away from mass culling of infected flocks.

The US Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) has issued a conditional license for an avian influenza vaccine, H5N2 subtype, killed virus. The vaccine, manufactured by Zoetis, is labeled for use in chickens.

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license